127 related articles for article (PubMed ID: 32892154)
1. Characterization of Seasonal Pharmacokinetic Variability in Woodchucks.
Zheng J; Balsitis S; Santos R; Smith BJ; Subramanian R
Drug Metab Dispos; 2020 Nov; 48(11):1199-1209. PubMed ID: 32892154
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
Korba BE; Cote P; Hornbuckle W; Tennant BC; Gerin JL
Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of (-)-2'-3'-dideoxy-3'-thiacytidine in woodchucks.
Rajagopalan P; Boudinot FD; Chu CK; Tennant BC; Baldwin BH; Schinazi RF
Antimicrob Agents Chemother; 1996 Mar; 40(3):642-5. PubMed ID: 8851586
[TBL] [Abstract][Full Text] [Related]
4. The woodchuck model of hepatitis B virus infection.
Tennant BC; Gerin JL
ILAR J; 2001; 42(2):89-102. PubMed ID: 11406711
[TBL] [Abstract][Full Text] [Related]
5. Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
Menne S; Asif G; Narayanasamy J; Butler SD; George AL; Hurwitz SJ; Schinazi RF; Chu CK; Cote PJ; Gerin JL; Tennant BC
Antimicrob Agents Chemother; 2007 Sep; 51(9):3177-84. PubMed ID: 17606676
[TBL] [Abstract][Full Text] [Related]
6. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
Menne S; Cote PJ; Korba BE; Butler SD; George AL; Tochkov IA; Delaney WE; Xiong S; Gerin JL; Tennant BC
Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
[TBL] [Abstract][Full Text] [Related]
7. The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.
Menne S; Cote PJ
World J Gastroenterol; 2007 Jan; 13(1):104-24. PubMed ID: 17206759
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
Le Guerhier F; Pichoud C; Jamard C; Guerret S; Chevallier M; Peyrol S; Hantz O; King I; Trépo C; Cheng YC; Zoulim F
Antimicrob Agents Chemother; 2001 Apr; 45(4):1065-77. PubMed ID: 11257017
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
Peek SF; Cote PJ; Jacob JR; Toshkov IA; Hornbuckle WE; Baldwin BH; Wells FV; Chu CK; Gerin JL; Tennant BC; Korba BE
Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
[TBL] [Abstract][Full Text] [Related]
10. Seasonal variations in circulating levels of progesterone and estradiol in unmated adult female woodchucks (Marmota monax) in captivity.
Hikim AP; Amador AG; Woolf A; Bartke A; Gremillion-Smith C
Life Sci; 1991; 49(5):353-9. PubMed ID: 1857185
[TBL] [Abstract][Full Text] [Related]
11. Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B.
Daffis S; Balsitis S; Chamberlain J; Zheng J; Santos R; Rowe W; Ramakrishnan D; Pattabiraman D; Spurlock S; Chu R; Kang D; Mish M; Ramirez R; Li L; Li B; Ma S; Hung M; Voitenleitner C; Yon C; Suresh M; Menne S; Cote P; Delaney WE; Mackman R; Fletcher SP
Hepatology; 2021 Jan; 73(1):53-67. PubMed ID: 32246499
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
Korba BE; Cote P; Hornbuckle W; Schinazi R; Gerin JL; Tennant BC
Antiviral Res; 2000 Jan; 45(1):19-32. PubMed ID: 10774587
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection.
Tennant BC; Baldwin BH; Graham LA; Ascenzi MA; Hornbuckle WE; Rowland PH; Tochkov IA; Yeager AE; Erb HN; Colacino JM; Lopez C; Engelhardt JA; Bowsher RR; Richardson FC; Lewis W; Cote PJ; Korba BE; Gerin JL
Hepatology; 1998 Jul; 28(1):179-91. PubMed ID: 9657111
[TBL] [Abstract][Full Text] [Related]
14. In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.
Cullen JM; Smith SL; Davis MG; Dunn SE; Botteron C; Cecchi A; Linsey D; Linzey D; Frick L; Paff MT; Goulding A; Biron K
Antimicrob Agents Chemother; 1997 Oct; 41(10):2076-82. PubMed ID: 9333028
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine.
Tatti KM; Korba BE; Stang HL; Peek S; Gerin JL; Tennant BC; Schinazi RF
Antiviral Res; 2002 Jul; 55(1):141-50. PubMed ID: 12076758
[TBL] [Abstract][Full Text] [Related]
16. Effect of body mass on hibernation strategies of woodchucks (Marmota monax).
Zervanos SM; Maher CR; Florant GL
Integr Comp Biol; 2014 Sep; 54(3):443-51. PubMed ID: 24345658
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant defense and protection against cardiac arrhythmias: lessons from a mammalian hibernator (the woodchuck).
Zhao Z; Kudej RK; Wen H; Fefelova N; Yan L; Vatner DE; Vatner SF; Xie LH
FASEB J; 2018 Aug; 32(8):4229-4240. PubMed ID: 29490168
[TBL] [Abstract][Full Text] [Related]
18. Myocardial ischemic protection in natural mammalian hibernation.
Yan L; Kudej RK; Vatner DE; Vatner SF
Basic Res Cardiol; 2015 Mar; 110(2):9. PubMed ID: 25613166
[TBL] [Abstract][Full Text] [Related]
19. Woodchuck hepatitis virus in natural woodchuck populations.
Tyler GV; Summers JW; Synder RL
J Wildl Dis; 1981 Apr; 17(2):297-301. PubMed ID: 7241716
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of biological rhythms during hibernation in Eastern woodchucks (Marmota monax).
Zervanos SM; Salsbury CM; Brown JK
J Comp Physiol B; 2009 May; 179(4):411-8. PubMed ID: 19107488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
